ArticlePloS one2024
Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approach.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Individualizing Kt by sex and body surface area: implications for survival in hemodialysis patients.Clinical kidney journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The dialysis dose, quantified as Kt, is conventionally scaled to the urea distribution volume (V) to calculate the Kt/V ratio as an indicator of dialysis adequacy. However, the body surface area (BSA) is recognized as a more accurate reflection of metabolic activity compared to V. This study presents evidence supporting the enhanced efficacy of the Kt/BSA ratio as an indicator of hemodialysis adequacy. The study population comprised 211 individuals undergoing hemodialysis, all of whom had Kt/V values determined. Body composition was assessed using bioimpedance techniques, and BSA was calculated employing the DuBois and DuBois formula. The ratio of V/BSA served as the conversion factor to derive Kt/BSA from the standard Kt/V. Participants were categorized by gender, and a comparative analysis was performed on dialysis-related parameters alongside body composition indicators. Concurrently, linear regression analysis was applied to Kt/V and Kt/BSA, as well as to pairs of V and BSA, to elucidate the relationships among these variables. The average Kt/V ratio was 1.50 with a standard deviation of 0.28. The Kt/V ratio was significantly higher in women (P < 0.01). Conversely, the Kt value, when not adjusted for body size, was significantly lower in women (P < 0.01). Upon scaling Kt to BSA to calculate Kt/BSA, the gender difference in dialysis dose adequacy was no longer statistically significant (P = 0.06). Men exhibited a significantly higher mean V/BSA ratio. Additionally, women had a slightly higher mean percentage of fat mass (P < 0.01). In contrast, women had a lower mean percentage of muscle mass (P < 0.01). Our findings suggest that the Kt/V ratio may underestimate the required hemodialysis dose for women. There was no gender difference when Kt scaling to BSA. Consequently, the Kt/BSA ratio, which accounts for body surface area, may play a significant role in more accurately scaling the hemodialysis dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.